Close Menu

NEW YORK – Biocept on Friday filed a shelf registration to publicly offer up to $100 million in a mix of securities.

The San Diego-based firm said in a document filed with the US Securities and Exchange Commission that it plans to offer from time to time securities that include shares of its common stock and preferred stock, various series of debt securities, and warrants to purchase any of such securities.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.